funding
Engie Brasil's share offering raises $1.7 billion
Engie Brasil raised $1.7 billion through a share offering.
Markets open original ↗
Importance is a model-assigned 1–5 on published stories, not a market forecast.
Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.
An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.
Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.
Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.
A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.
Mon · 12 Oct · today
Tue · 13 Oct
Wed · 15 Jul
funding
Engie Brasil raised $1.7 billion through a share offering.
Markets open original ↗
earnings
Genmab announced its Darzalex net sales figures for the second quarter of 2026.
Markets open original ↗
earnings
Tianqi Lithium issued a profit forecast projecting first-half net profit up roughly 3,276% to 4,935% year-on-year.
Markets open original ↗
earnings
Surging lab-monkey prices helped JOINN Laboratories' first-half net profit soar over 1,300%.
Markets open original ↗
regulation
Kelun-Biotech and Harbour BioMed announced NMPA approval of an IND application for SKB575/HBM7575 to treat asthma.
Markets open original ↗